| 1 |
Committee for Guidelines for Management of Dyslipidemia. Guidelines for management of dyslipidemia. 2nd ed. Seoul: Korean Society of Lipidology and Atherosclerosis; 2009.
|
| 2 |
European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D; ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees. ESC/EAS guidelines for the management of dyslipidae-mias: the Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011;32:1769-1818.
DOI
|
| 3 |
Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW, Eddleman KM, Jarrett NM, LaBresh K, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Associa-tion Task Force on Practice Guidelines. Circulation 2014;129(25 Suppl 2):S1-S45.
DOI
|
| 4 |
Committee for Guidelines for Management of Dyslipidemia. 2015 Korean guidelines for management of dyslipidemia. J Lipid Atheroscler 2015;4:61-92.
DOI
|
| 5 |
Jee SH, Jang Y, Oh DJ, Oh BH, Lee SH, Park SW, Seung KB, Mok Y, Jung KJ, Kimm H, Yun YD, Baek SJ, Lee DC, Choi SH, Kim MJ, Sung J, Cho B, Kim ES, Yu BY, Lee TY, Kim JS, Lee YJ, Oh JK, Kim SH, Park JK, Koh SB, Park SB, Lee SY, Yoo CI, Kim MC, Kim HK, Park JS, Kim HC, Lee GJ, Woodward M. A coronary heart disease prediction model: the Korean Heart Study. BMJ Open 2014;4:e005025.
DOI
|
| 6 |
Arai H, Sasaki J, Teramoto T. Comment on the new guidelines in USA by the JAS guidelines committee. J Atheroscler Thromb 2014;21:79-81.
DOI
|
| 7 |
Kwon JE, Kim Y, Hyun S, Won H, Shin SY, Lee KJ, Kim SW, Kim TH, Kim CJ. Cholesterol lowering effects of low-dose statins in Korean patients. J Lipid Atheroscler 2014;3:21-28.
DOI
|
| 8 |
Vaucher J, Marques-Vidal P, Preisig M, Waeber G, Vollenweider P. Population and economic impact of the 2013 ACC/AHA guide-lines compared with European guidelines to prevent car-diovascular disease. Eur Heart J 2014;35:958-959.
DOI
|
webmaster
